1 Biological and immunological properties of insulin-like growth factors (IGF) I and II

https://doi.org/10.1016/S0300-595X(84)80006-7Get rights and content

First page preview

First page preview
Click to open first page preview

References (81)

  • MeuliC. et al.

    Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart

    Biochemical and Biophysical Research Communications

    (1977)
  • RechlerM.M. et al.

    Characterization of the binding of multiplication stimulating activity to a receptor for growth polypeptides in chick embyro fibroblasts

    Journal of Biological Chemistry

    (1977)
  • RinderknechtE. et al.

    The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin

    Journal of Biological Chemistry

    (1978)
  • RinderknechtE. et al.

    Primary structure of human insulin-like growth factor II

    FEBS Letters

    (1978)
  • SchmidC.H. et al.

    Parathormone promotes glycogen formation from 14C-glucose in cultured osteoblast-like cells

    FEBS Letters

    (1982)
  • SchmidC.H. et al.

    Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and II) in primary cultures of chick embryonic cells

    FEBS Letters

    (1983)
  • ScottB.L. et al.

    Distribution of glycogen in osteoblasts of the fetal rat

    Journal of Ultrastructural Research

    (1971)
  • ZapfJ. et al.

    The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role

    Current Topics in Cellular Regulation

    (1981)
  • ZapfJ. et al.

    Binding of nonsuppressible insulin-like activity to human serum. Evidence for a carrier protein

    Archives of Biochemistry and Biophysics

    (1975)
  • ZapfJ. et al.

    Specific binding of nonsuppressible insulin-like activity to chicken embryo fibroblasts and to a solublized fibroblast receptor

    Archives of Biochemistry and Biophysics

    (1975)
  • ZapfJ. et al.

    Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight form

    FEBS Letters

    (1978)
  • AntoniadesH.N. et al.

    Radioimmunoassay of a human serum growth factor for Balb/C-3T3 cells: derivation from platelets

  • AudhyaT.K. et al.

    Enhancement of somatomedin titres of normal and hypopituitary sera by addition of L-trilodothyronine in vitro at physiological concentrations

  • BalaR.M. et al.

    Purification of a basic somatomedin, from human plasma Cohn fraction IV-1, with physicochemical and radioimmunoassay similarity to somatomedin C and insulin-like growth factor I

    Canadian Journal of Biochemistry

    (1979)
  • BarR.S. et al.

    Receptors for multiplication stimulating activity on human arterial and venous endothelial cells

    Journal of Clinical Endocrinology and Metabolism

    (1980)
  • BarR.S. et al.

    Interactions of multiplication stimulating activity with bovine endothelium: comparative studies in primary, passaged, and cloned cultures from the pulmonary and systemic circulations

    Endocrinology

    (1982)
  • BlundellT.L. et al.

    Insulin-like growth factors: a model for tertiary structure accounting for immunoreactivity and receptor binding

  • CanalisE.

    Effect of insulin-like growth factor I on DNA and protein synthesis in cultured rat calvaria

    Journal of Clinical Investigation

    (1980)
  • DaughadayW.H. et al.

    Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native acid-ethanol-extracted serum

    Journal of Clinical Endocrinology and Metabolism

    (1980)
  • DaughadayW.H. et al.

    Somatomedin: proposed designation for sulfation factor

    Nature

    (1972)
  • DaughadayW.H. et al.

    Measurement of somatomedinrelated peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF II radioreceptor assay (RRA) and multiplication stimulating activity RRA after acid-ethanol extraction

    Endocrinology

    (1982)
  • de la HabaG. et al.

    Hormonal requirements for myogenesis of striated muscle in vitro: insulin and somatotropin

  • DropS.L.S. et al.

    Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity

    Acta Endocrinologica (Kbh.)

    (1979)
  • EllisS. et al.

    Influence of hypophysectomy and growth hormone on cartilage sulfate metabolism

  • EllisS. et al.

    Stimulation of body weight increase and epiphyseal cartilage growth in hypophysectomized rats by insulin-like growth factor

  • FroeschE.R. et al.

    Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity

    Journal of Clinical Investigation

    (1963)
  • FroeschE.R. et al.

    Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage

  • FurlanettoR.W. et al.

    Estimation of somatomedin-C levels in normals and patients with pituitary disease ny radioimmunoassay

    Journal of Clinical Investigation

    (1977)
  • HallK. et al.

    Somatomedins

  • HallK. et al.

    Immunoreactive somatomedin A in human serum

    Journal of Clinical Endocrinology and Metabolism

    (1979)
  • Cited by (225)

    • Diabetes and the Female Reproductive System

      2013, Endocrinology and Metabolism Clinics of North America
      Citation Excerpt :

      Insulin and IGF-1 are closely related peptides. They share sequence homology and have nearly identical 3-D structures.35 The hormone receptors also have significant homology, featuring a heterotetrameric structure where 2 α subunits serve as the hormone binding site and 2 β subunits become autophosphorylated and acquire tyrosine kinase activity.

    • Insulin-like growth factor - Oestradiol crosstalk and mammary gland tumourigenesis

      2013, Biochimica et Biophysica Acta - Reviews on Cancer
      Citation Excerpt :

      Ancillary members of the axis include IGFBP related proteins IGFBPrP-1 and 2 — sometimes called IGFBP-7 and -8 [3,4], specific and non-specific IGFBP proteases [5] and an acid labile subunit (ALS) protein which complexes with IGFBP-3 and IGFBP-5 in serum and interstitial fluids [6]. IGF-1 and -2 are small (~ 7.5 kDa) polypeptides which show structural and functional homology to insulin [7] although unlike insulin IGFs are expressed by several tissues and cell types. The IGF-1R also shows a high degree of homology with the insulin receptor (IR) and hybrid IGF-1R/insulin receptor species have been reported for both the A and B isoforms of the insulin receptor (IR-A/IR-B) comprising an IGF-1R αβ dimer combined with an αβ dimer of the IR-A or IR-B isoform.

    • Separation of minor protein components from whey protein isolates by heparin affinity chromatography

      2008, International Dairy Journal
      Citation Excerpt :

      IGF-I is a mitogenic polypeptide structurally similar to insulin. This molecule has a role in the development of various tissues and stimulates cellular growth, differentiation and metabolism (Guvakova, 2007; Zapf, Schmid, & Froesch, 1984). TGF-β2 is bound to a latent binding protein and liberated by acidic or basic pH, heat-treatment, changes in ionic strength, or various chaotropic agents (Elfstrand, Lindmark-Månsson, Paulsson, Nyberg, & Åkesson, 2002; Gauthier et al., 2006).

    • Pathobiology of Tendon and Ligament Injuries

      2007, Clinical Techniques in Equine Practice
      Citation Excerpt :

      As the proliferative phase of healing progressed, GAG content increased to levels slightly above those of normal tendon.38 Growth factors are peptide signaling molecules that influence a diverse array of biological functions, including cell metabolism, cell proliferation and differentiation, and the production of ECM molecules.42-44 IGF-I and TGF-β1 effect a range of anabolic responses desirable in the treatment of musculoskeletal disorders, including cell proliferation and ECM production.

    View all citing articles on Scopus
    View full text